Valeant Pharmaceuticals International (VRX) 75.41 $VRX
10 Stocks That Have Made Julian Robertson's Tiger Cubs a Lot of Money
at The Street - 1 hr 22 mins ago
Hedge fund legend Julian Roberts' disciples know how to pick 'em. These 10 stocks have been their biggest winners over the past decade.
AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), CHTR: 186.48 (-5.52), LNG: 46.12 (+1.24), PCLN: 1,297.75 (-16.26), NFLX: 103.65 (-5.27), BIDU: 193.95 (-4.19), TDG: 229.72 (+0.22), GOOGL: 740.07 (-16.46), FLT: 146.82 (-3.81), JD: 26.75 (-2.03), AAPL: 112.34 (-3.38), MA: 96.86 (-1.42)
5 Drugs That Are the Face of Prescription Drug Reform
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 15, 8:41AM CST
Image source: Flickr user StockMonkeys.com. Think fast: what's the first thing that comes to mind when I say "prescription drugs?" Were you too busy reaching for your wallet to think of anything? Don't worry, you're probably not alone. ...
MNK: 56.94 (+3.53), VRX: 75.41 (+1.64), VRTX: 123.05 (+5.75), GILD: 102.57 (-1.66)
What an Old Bull Looks Like; A Technological Tidal Wave: Best of Kass
at The Street - Fri Nov 13, 8:00PM CST
In highlights from this week's trading diary and posts, Kass discusses why this bull market reminds him of himself, and why the tech transformation hitting retail is just the start.
WFM: 29.55 (-0.36), MNK: 56.94 (+3.53), AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), GM: 34.31 (-0.78), M: 39.10 (-1.72), CAT: 69.63 (+0.97)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Valeant Pharmaceuticals International, Inc. of Class Action Lawsuit and Upcoming Deadline - VRX
GlobeNewswire - Fri Nov 13, 3:39PM CST
Pomerantz LLP announces that a class action lawsuit has been filed against Valeant Pharmaceuticals International Inc. ("Valeant" or the "Company"
(NYSE:VRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased Valeant securities between February 23, 2015 and October 20, 2015 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
VRX: 75.41 (+1.64), VRX.TO: 100.53 (+2.39)
We're Not in a Bubble, It's Already Popped
at The Street - Fri Nov 13, 2:30PM CST
Some predict a looming crash, but many stocks have just had one.
AMZN: 642.35 (-23.25), GPRO: 21.16 (-1.99), VRX: 75.41 (+1.64), ABX: 7.54 (-0.01), VJET: 5.69 (+0.02), FB: 103.95 (-4.07), DDD: 8.75 (+0.23), GOOG: 717.00 (-14.23), BTU: 13.79 (+0.28), FOSL: 32.39 (-18.62), SUNE: 4.93 (+0.39), CHK: 6.10 (-0.22), SSYS: 22.86 (-0.51), GOOGL: 740.07 (-16.46), GDX: 13.62 (+0.15), AAPL: 112.34 (-3.38), GG: 12.01 (+0.18)
Why Concordia Healthcare Corp Is Shooting Higher Today
Brian Feroldi, The Motley Fool - Motley Fool - Fri Nov 13, 1:59PM CST
What: Shares of Concordia Healthcare , a Canadian-based pharmaceutical company, were up more than 15% in afternoon trading after the company reported third quarter earnings that impressed Wall Street. So what: The company's growth by...
VRX: 75.41 (+1.64)
Trader's Notebook: Russell 2K ETF Drops 2%
at The Street - Fri Nov 13, 8:00AM CST
Bottom fishers in the IWM should keep an eye on its 50-day moving average.
VRX: 75.41 (+1.64), DIA: 172.61 (-2.06), IWM: 114.07 (-0.83)
Jim Cramer: Why the Fed Is the Stock Market’s Enemy Right Now
at The Street - Fri Nov 13, 5:10AM CST
With heighten speculation the Fed will raise rates in December, Cramer weighs in on why the Fed is the market's adversary.
AGN: 299.63 (-0.41), NFLX: 103.65 (-5.27), DHI: 30.67 (-0.32), AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), MCD: 109.97 (-2.14), STZ: 132.20 (-1.18), GOOGL: 740.07 (-16.46)
Nordstrom Adds to Retail Pain With Disappointing Earnings Results
at The Street - Fri Nov 13, 4:00AM CST
The CNBC 'Fast Money' traders examine stocks after a rough day of trading Thursday, before turning their attention to the struggling retail sector.
VRX: 75.41 (+1.64), HD: 120.00 (-3.81), SHAK: 40.85 (-1.62), NKE: 121.86 (-4.12), M: 39.10 (-1.72), UA: 87.43 (-4.93), SPY: 202.54 (-2.30), TJX: 64.21 (-4.04), ERIC: 9.24 (-0.01), SUNE: 4.93 (+0.39), CMG: 592.89 (-21.79), JWN: 53.96 (-9.51), MCD: 109.97 (-2.14), CSCO: 26.21 (-1.62)
Valeant Pharmaceuticals To Present At Industry Conference
CNW Group - Thu Nov 12, 7:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will be presenting at the Jefferies Autumn 2015 Global Healthcare Conference in London, UK.
VRX: 75.41 (+1.64), VRX.TO: 100.53 (+2.39)
Gilead, Regeneron Stocks Weather Drug Pricing Furor
at Investor's Business Daily - Thu Nov 12, 5:30PM CST
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry's drug-pricing practices and fears of...
MNK: 56.94 (+3.53), ESRX: 82.99 (-1.47), VRX: 75.41 (+1.64), GILD: 102.57 (-1.66), HZNP: 17.99 (+0.38), SNY: 42.99 (-0.65), REGN: 548.90 (-3.63)
SmarTrend Watching for Potential Rebound in Shares of Valeant Pharmaceuticals International After 6.50% Loss
Comtex SmarTrend(R) - Thu Nov 12, 4:36PM CST
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $73.69 to a high of $77.00. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of $78.60 on volume of 17.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 75.41 (+1.64)
Horizon (HZNP) Slips, Comments on Express Scripts Charges
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 3:45PM CST
Horizon Pharma plc (HZNP) tumbled 19.6% after it commented on Express Scripts Holding Company's (ESRX) business practices.
VRX: 75.41 (+1.64), ESRX: 82.99 (-1.47), HZNP: 17.99 (+0.38)
Valeant (VRX) Stock Falls Further on Insider Trading Suit
at The Street - Thu Nov 12, 1:34PM CST
Valeant (VRX) stock is continuing yesterday's decline in afternoon trading on Thursday, after a judge ruled the company and Bill Ackman must face a shareholder lawsuit alleging insider trading.
VRX: 75.41 (+1.64)
Regeneron Recovers From Clinton Biotech Beat Down
at Investor's Business Daily - Thu Nov 12, 10:27AM CST
Biotech stocks and drugmakers like Valeant Pharmaceuticals (VRX) took a beating in September when Hillary Clinton accused Big Pharma of price gouging. But Regeneron Pharmaceuticals (REGN) has now bounced back into a buy zone. The New York-based...
VRX: 75.41 (+1.64), GILD: 102.57 (-1.66), AMGN: 151.55 (+0.57), SNY: 42.99 (-0.65), REGN: 548.90 (-3.63)
EyeGate Reports Third Quarter 2015 Financial Results and Provides Business Update
GlobeNewswire - Thu Nov 12, 7:30AM CST
Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company", a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced financial results for the three months ended September 30, 2015 and provided an update on recent strategic and operational initiatives.
VRX: 75.41 (+1.64), EYEG: 3.46 (-0.31), VRX.TO: 100.53 (+2.39)
Nov. 12 Premarket Briefing: 10 Things You Should Know
at The Street - Thu Nov 12, 5:49AM CST
U.S. stock futures rise slightly Thursday ahead of remarks from a number of top Federal Reserve officials.
AGN: 299.63 (-0.41), KSS: 42.85 (-2.94), VRX: 75.41 (+1.64), ANGI: 9.79 (+0.82), WMT: 56.42 (-0.53), IACI: 65.00 (-0.24), PYPL: 34.53 (-1.04), AAPL: 112.34 (-3.38), VIAB: 49.99 (+0.20), CSCO: 26.21 (-1.62), MS: 33.93 (-0.30)
Ackman, Munger spar at event
at Investor's Business Daily - Wed Nov 11, 5:48PM CST
Bill Ackman, head of the Pershing Square hedge fund, was at a symposium commemorating Warren Buffett's 50-year rein at Berkshire Hathaway (BRKB). Berkshire Vice Chair Charles Munger criticized Valeant Pharmaceuticals (VRX), a big holding for Ackman's...
KO: 41.38 (-0.20), VRX: 75.41 (+1.64)
10 Stocks That Have Made Julian Robertson's Tiger Cubs a Lot of Money
at The Street - 1 hr 22 mins ago
Hedge fund legend Julian Roberts' disciples know how to pick 'em. These 10 stocks have been their biggest winners over the past decade.
AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), CHTR: 186.48 (-5.52), LNG: 46.12 (+1.24), PCLN: 1,297.75 (-16.26), NFLX: 103.65 (-5.27), BIDU: 193.95 (-4.19), TDG: 229.72 (+0.22), GOOGL: 740.07 (-16.46), FLT: 146.82 (-3.81), JD: 26.75 (-2.03), AAPL: 112.34 (-3.38), MA: 96.86 (-1.42)
5 Drugs That Are the Face of Prescription Drug Reform
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 15, 8:41AM CST
Image source: Flickr user StockMonkeys.com. Think fast: what's the first thing that comes to mind when I say "prescription drugs?" Were you too busy reaching for your wallet to think of anything? Don't worry, you're probably not alone. ...
MNK: 56.94 (+3.53), VRX: 75.41 (+1.64), VRTX: 123.05 (+5.75), GILD: 102.57 (-1.66)
What an Old Bull Looks Like; A Technological Tidal Wave: Best of Kass
at The Street - Fri Nov 13, 8:00PM CST
In highlights from this week's trading diary and posts, Kass discusses why this bull market reminds him of himself, and why the tech transformation hitting retail is just the start.
WFM: 29.55 (-0.36), MNK: 56.94 (+3.53), AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), GM: 34.31 (-0.78), M: 39.10 (-1.72), CAT: 69.63 (+0.97)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Valeant Pharmaceuticals International, Inc. of Class Action Lawsuit and Upcoming Deadline - VRX
GlobeNewswire - Fri Nov 13, 3:39PM CST
Pomerantz LLP announces that a class action lawsuit has been filed against Valeant Pharmaceuticals International Inc. ("Valeant" or the "Company"
(NYSE:VRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased Valeant securities between February 23, 2015 and October 20, 2015 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". VRX: 75.41 (+1.64), VRX.TO: 100.53 (+2.39)
We're Not in a Bubble, It's Already Popped
at The Street - Fri Nov 13, 2:30PM CST
Some predict a looming crash, but many stocks have just had one.
AMZN: 642.35 (-23.25), GPRO: 21.16 (-1.99), VRX: 75.41 (+1.64), ABX: 7.54 (-0.01), VJET: 5.69 (+0.02), FB: 103.95 (-4.07), DDD: 8.75 (+0.23), GOOG: 717.00 (-14.23), BTU: 13.79 (+0.28), FOSL: 32.39 (-18.62), SUNE: 4.93 (+0.39), CHK: 6.10 (-0.22), SSYS: 22.86 (-0.51), GOOGL: 740.07 (-16.46), GDX: 13.62 (+0.15), AAPL: 112.34 (-3.38), GG: 12.01 (+0.18)
Why Concordia Healthcare Corp Is Shooting Higher Today
Brian Feroldi, The Motley Fool - Motley Fool - Fri Nov 13, 1:59PM CST
What: Shares of Concordia Healthcare , a Canadian-based pharmaceutical company, were up more than 15% in afternoon trading after the company reported third quarter earnings that impressed Wall Street. So what: The company's growth by...
VRX: 75.41 (+1.64)
Trader's Notebook: Russell 2K ETF Drops 2%
at The Street - Fri Nov 13, 8:00AM CST
Bottom fishers in the IWM should keep an eye on its 50-day moving average.
VRX: 75.41 (+1.64), DIA: 172.61 (-2.06), IWM: 114.07 (-0.83)
Jim Cramer: Why the Fed Is the Stock Market’s Enemy Right Now
at The Street - Fri Nov 13, 5:10AM CST
With heighten speculation the Fed will raise rates in December, Cramer weighs in on why the Fed is the market's adversary.
AGN: 299.63 (-0.41), NFLX: 103.65 (-5.27), DHI: 30.67 (-0.32), AMZN: 642.35 (-23.25), VRX: 75.41 (+1.64), FB: 103.95 (-4.07), MCD: 109.97 (-2.14), STZ: 132.20 (-1.18), GOOGL: 740.07 (-16.46)
Nordstrom Adds to Retail Pain With Disappointing Earnings Results
at The Street - Fri Nov 13, 4:00AM CST
The CNBC 'Fast Money' traders examine stocks after a rough day of trading Thursday, before turning their attention to the struggling retail sector.
VRX: 75.41 (+1.64), HD: 120.00 (-3.81), SHAK: 40.85 (-1.62), NKE: 121.86 (-4.12), M: 39.10 (-1.72), UA: 87.43 (-4.93), SPY: 202.54 (-2.30), TJX: 64.21 (-4.04), ERIC: 9.24 (-0.01), SUNE: 4.93 (+0.39), CMG: 592.89 (-21.79), JWN: 53.96 (-9.51), MCD: 109.97 (-2.14), CSCO: 26.21 (-1.62)
Valeant Pharmaceuticals To Present At Industry Conference
CNW Group - Thu Nov 12, 7:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will be presenting at the Jefferies Autumn 2015 Global Healthcare Conference in London, UK.
VRX: 75.41 (+1.64), VRX.TO: 100.53 (+2.39)
Gilead, Regeneron Stocks Weather Drug Pricing Furor
at Investor's Business Daily - Thu Nov 12, 5:30PM CST
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry's drug-pricing practices and fears of...
MNK: 56.94 (+3.53), ESRX: 82.99 (-1.47), VRX: 75.41 (+1.64), GILD: 102.57 (-1.66), HZNP: 17.99 (+0.38), SNY: 42.99 (-0.65), REGN: 548.90 (-3.63)
SmarTrend Watching for Potential Rebound in Shares of Valeant Pharmaceuticals International After 6.50% Loss
Comtex SmarTrend(R) - Thu Nov 12, 4:36PM CST
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $73.69 to a high of $77.00. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of $78.60 on volume of 17.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 75.41 (+1.64)
Horizon (HZNP) Slips, Comments on Express Scripts Charges
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 3:45PM CST
Horizon Pharma plc (HZNP) tumbled 19.6% after it commented on Express Scripts Holding Company's (ESRX) business practices.
VRX: 75.41 (+1.64), ESRX: 82.99 (-1.47), HZNP: 17.99 (+0.38)
Valeant (VRX) Stock Falls Further on Insider Trading Suit
at The Street - Thu Nov 12, 1:34PM CST
Valeant (VRX) stock is continuing yesterday's decline in afternoon trading on Thursday, after a judge ruled the company and Bill Ackman must face a shareholder lawsuit alleging insider trading.
VRX: 75.41 (+1.64)
Regeneron Recovers From Clinton Biotech Beat Down
at Investor's Business Daily - Thu Nov 12, 10:27AM CST
Biotech stocks and drugmakers like Valeant Pharmaceuticals (VRX) took a beating in September when Hillary Clinton accused Big Pharma of price gouging. But Regeneron Pharmaceuticals (REGN) has now bounced back into a buy zone. The New York-based...
VRX: 75.41 (+1.64), GILD: 102.57 (-1.66), AMGN: 151.55 (+0.57), SNY: 42.99 (-0.65), REGN: 548.90 (-3.63)
EyeGate Reports Third Quarter 2015 Financial Results and Provides Business Update
GlobeNewswire - Thu Nov 12, 7:30AM CST
Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Company"
, a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced financial results for the three months ended September 30, 2015 and provided an update on recent strategic and operational initiatives. VRX: 75.41 (+1.64), EYEG: 3.46 (-0.31), VRX.TO: 100.53 (+2.39)
Nov. 12 Premarket Briefing: 10 Things You Should Know
at The Street - Thu Nov 12, 5:49AM CST
U.S. stock futures rise slightly Thursday ahead of remarks from a number of top Federal Reserve officials.
AGN: 299.63 (-0.41), KSS: 42.85 (-2.94), VRX: 75.41 (+1.64), ANGI: 9.79 (+0.82), WMT: 56.42 (-0.53), IACI: 65.00 (-0.24), PYPL: 34.53 (-1.04), AAPL: 112.34 (-3.38), VIAB: 49.99 (+0.20), CSCO: 26.21 (-1.62), MS: 33.93 (-0.30)
Ackman, Munger spar at event
at Investor's Business Daily - Wed Nov 11, 5:48PM CST
Bill Ackman, head of the Pershing Square hedge fund, was at a symposium commemorating Warren Buffett's 50-year rein at Berkshire Hathaway (BRKB). Berkshire Vice Chair Charles Munger criticized Valeant Pharmaceuticals (VRX), a big holding for Ackman's...
KO: 41.38 (-0.20), VRX: 75.41 (+1.64)
